The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Exactly Trendz.....laymen terms. Tell everone what it really means so they can understand the potential benefits. One negative word is taken out of context and causes an sp disaster!
Well, hopefully some serious investors pick up on it in a couple of weeks time at the conference - effectively 4d could well be providing data showing the discovery of a new neoadjuvant immunotherapy. I.e. put in layman's term, a new safe alternative to chemo and radiation.
The company will need to spell it out for idiots! "4D Pharma discovers new treatment for cancer". Still 125m market cap tho!
Totally agree with this. Went back to look at the exact wording and this was posted by noix last week as a direct quote:
Around 9 mins 20 secs in:
"We are right at the forefront of making checkpoint inhibitors potentially more effective but also 0518 WORKS AS A MONOTHERAPY AS WELL’
Your are absolutely right, a treatment for tumours with no side affects and that ‘works’ would be absolutely huge. It’s hard not to conclude that that is the data that will be shared in November from the comments and hard not to believe the market cap will be many multiples of today if true.
Whether a slip up or not it’s a huge, huge hint that I don’t feel is being given anything like the attention it deserves. It’s been a bit painful here over the last couple of weeks but that does give an incredible price for a top up (which I’ve done today significantly) At a ridiculously low price for the potential.
Gents - anyone got any views on the below? If i'm correct and the data being presented on 14 November shows that MRx0518 is equally good as a mono-therapy, is this not huge news? would this not be the first ever data sowing a potential stand alone alternative to chemo and radiation?
So, the MRx0518 solid tumours Phase I trial results are due any day now (before the 11 November 2020 SITC presentation).
"The first poster will describe initial immune modulation and safety data from the MRx0518 neoadjuvant monotherapy trial in patients awaiting surgical resection of solid tumors."
Have we heard a serious slip up from Duncan in his recent TV interview? I'm sure he said that MRx0518 works effectively and safely as a monotherapy drug, so I would imagine these results are going to be positive?! If they are, are we not talking HUGE HUGE news? I.e. MRx0518 can effectively treat tumors? I mean, if so, this is monumentally groundbreaking, no??! A new way to treat tumours that has no side effects like Chemo, radiation, surgery.
I'm not sure if i'm going mad or not but I just can't help but feel that 4D should be valued at a completely different level. I mean, just looking at oncology and disregarding everything else going on at DDDD), 125m value for a new tumor monotherapy????
These results will be out in the next three weeks. If the results are good and the market cap is still 125m then i'm going to need to go and visit Duncan P to understand what i'm missing here!